U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 500

1.
Comparison of Insulators and Promoters for Expression of the Wiskott–Aldrich Syndrome Protein Using Lentiviral Vectors
Rachel M. Koldej, Gael Carney, Matthew M. Wielgosz, Sheng Zhou, Jun Zhan, Brian P. Sorrentino, Arthur W. Nienhuis
Hum Gene Ther Clin Dev. 2013 Jun; 24(2): 77–85. Published online 2013 May 2. doi: 10.1089/humc.2012.244
PMCID:
PMC4003467
AbstractArticlePDF–515K
2.
Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism
Genny Meini, Angelo Materazzi, Francesco Saladini, Andrea Rosi, Ilaria Vicenti, Michele Mancini, Antonella Pirazzoli, Cinzia Caudai, Maurizio Zazzi
BMC Infect Dis. 2013; 13: 508. Published online 2013 Oct 30. doi: 10.1186/1471-2334-13-508
PMCID:
PMC3819463
AbstractArticlePDF–159K
3.
HIV associated high-risk HPV infection among Nigerian women
Sally N Akarolo-Anthony, Maryam Al-Mujtaba, Ayotunde O Famooto, Eileen O Dareng, Olayinka B Olaniyan, Richard Offiong, Cosette M Wheeler, Clement A Adebamowo
BMC Infect Dis. 2013; 13: 521. Published online 2013 Nov 5. doi: 10.1186/1471-2334-13-521
PMCID:
PMC3826514
AbstractArticlePDF–244K
4.
Impact of Helminth Diagnostic Test Performance on Estimation of Risk Factors and Outcomes in HIV-Positive Adults
Michael B. Arndt, Grace John-Stewart, Barbra A. Richardson, Benson Singa, Lisette van Lieshout, Jaco J. Verweij, Laura R. Sangaré, Loice W. Mbogo, Jacqueline M. Naulikha, Judd L. Walson
PLoS One. 2013; 8(12): e81915. Published online 2013 Dec 4. doi: 10.1371/journal.pone.0081915
PMCID:
PMC3852669
AbstractArticlePDF–581K
5.
Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C
Arvind Reddy, Elizabeth May, Murray Ehrinpreis, Milton Mutchnick
World J Gastroenterol. 2013 Dec 28; 19(48): 9328–9333. Published online 2013 Dec 28. doi: 10.3748/wjg.v19.i48.9328
PMCID:
PMC3882405
AbstractArticlePDF–1.0M
6.
Class-Sparing Regimens for Initial Treatment of HIV-1 Infection
Sharon A. Riddler, Richard Haubrich, A. Gregory DiRienzo, Lynne Peeples, William G. Powderly, Karin L. Klingman, Kevin W. Garren, Tania George, James F. Rooney, Barbara Brizz, Umesh G. Lalloo, Robert L. Murphy, Susan Swindells, Diane Havlir, John W. Mellors
N Engl J Med. Author manuscript; available in PMC 2014 Jan 9.
Published in final edited form as: N Engl J Med. 2008 May 15; 358(20): 10.1056/NEJMoa074609. doi: 10.1056/NEJMoa074609
PMCID:
PMC3885902
AbstractArticlePDF–1017K
7.
Comparable Long-Term Efficacy of Lopinavir/Ritonavir and Similar Drug-Resistance Profiles in Different HIV-1 Subtypes
Zehava Grossman, Jonathan M. Schapiro, Itzchak Levy, Daniel Elbirt, Michal Chowers, Klaris Riesenberg, Karen Olstein-Pops, Eduardo Shahar, Valery Istomin, Ilan Asher, Bat-Sheva Gottessman, Yonat Shemer, Hila Elinav, Gamal Hassoun, Shira Rosenberg, Diana Averbuch, Keren Machleb-Guri, Zipi Kra-Oz, Sara Radian-Sade, Hagit Rudich, Daniela Ram, Shlomo Maayan, Nancy Agmon-Levin, Zev Sthoeger
PLoS One. 2014; 9(1): e86239. Published online 2014 Jan 27. doi: 10.1371/journal.pone.0086239
PMCID:
PMC3903498
AbstractArticlePDF–281K
8.
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group
V. Svicher, C. Alteri, M. Montano, A. Nori, R. D’Arrigo, M. Andreoni, G. Angarano, A. Antinori, G. Antonelli, T. Allice, P. Bagnarelli, F. Baldanti, A. Bertoli, M. Borderi, E. Boeri, I. Bon, B. Bruzzone, R. Barresi, S. Calderisi, A. P. Callegaro, M. R. Capobianchi, F. Gargiulo, F. Castelli, R. Cauda, F. Ceccherini-Silberstein, M. Clementi, A. Chirianni, M. Colafigli, A. D’Arminio Monforte, A. De Luca, A. Di Biagio, G. Di Nicuolo, G. Di Perri, F. Di Santo, G. Fadda, M. Galli, W. Gennari, V. Ghisetti, A. Costantini, A. Gori, R. Gulminetti, F. Leoncini, G. Maffongelli, F. Maggiolo, R. Maserati, F. Mazzotta, G. Meini, V. Micheli, L. Monno, C. Mussini, S. Nozza, S. Paolucci, G. Palù, S. Parisi, G. Parruti, A. R. Pignataro, T. Quirino, M. C. Re, G. Rizzardini, M. Sanguinetti, R. Santangelo, R. Scaggiante, G. Sterrantino, O. Turriziani, M. L. Vatteroni, C. Viscoli, V. Vullo, M. Zazzi, A. Lazzarin, C. F. Perno
Infection. 2014; 42(1): 61–71. Published online 2013 Oct 22. doi: 10.1007/s15010-013-0510-3
PMCID:
PMC3906530
AbstractArticlePDF–452K
9.
Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch
Victoria Johnston, Karen Cohen, Lubbe Wiesner, Lynn Morris, Johanna Ledwaba, Katherine L. Fielding, Salome Charalambous, Gavin Churchyard, Andrew Phillips, Alison D. Grant
J Infect Dis. 2014 Mar 1; 209(5): 711–720. Published online 2013 Aug 13. doi: 10.1093/infdis/jit411
PMCID:
PMC3923537
AbstractArticlePDF–302K
10.
Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations
Susana Monge, Vicente Guillot, Marta Alvarez, Natalia Chueca, Natalia Stella, Alejandro Peña, Rafael Delgado, Juan Córdoba, Antonio Aguilera, Carmen Vidal, Federico García, CoRIS
PLoS One. 2014; 9(3): e90710. Published online 2014 Mar 17. doi: 10.1371/journal.pone.0090710
PMCID:
PMC3956602
AbstractArticlePDF–294K
11.
Genetic Variation In Vitro and In Vivo of an Attenuated Lassa Vaccine Candidate
Juan C. Zapata, Marco Goicochea, Yuka Nadai, Lindsay M. Eyzaguirre, Jean K. Carr, Luke J. Tallon, Lisa Sadzewicz, Garry Myers, Claire M. Fraser, Qi Su, Mahmoud Djavani, Igor S. Lukashevich, Maria S. Salvato
J Virol. 2014 Mar; 88(6): 3058–3066. doi: 10.1128/JVI.03035-13
PMCID:
PMC3957910
AbstractArticlePDF–1.6M
12.
Acute hepatitis B of genotype H resulting in persistent infection
Norie Yamada, Ryuta Shigefuku, Ryuichi Sugiyama, Minoru Kobayashi, Hiroki Ikeda, Hideaki Takahashi, Chiaki Okuse, Michihiro Suzuki, Fumio Itoh, Hiroshi Yotsuyanagi, Kiyomi Yasuda, Kyoji Moriya, Kazuhiko Koike, Takaji Wakita, Takanobu Kato
World J Gastroenterol. 2014 Mar 21; 20(11): 3044–3049. Published online 2014 Mar 21. doi: 10.3748/wjg.v20.i11.3044
PMCID:
PMC3961985
AbstractArticlePDF–1.0M
13.
HIV Positivity but not HPV/p16 Status is Associated with Higher Recurrence Rate in Anal Cancer
Joshua E. Meyer, Vinicius J. A. Panico, Heloisa M. F. Marconato, David L. Sherr, Paul Christos, Edyta C. Pirog
J Gastrointest Cancer. Author manuscript; available in PMC 2014 Mar 24.
Published in final edited form as: J Gastrointest Cancer. 2013 Dec; 44(4): 450–455. doi: 10.1007/s12029-013-9543-1
PMCID:
PMC3963822
AbstractArticlePDF–396K
14.
HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-Blood Compartments from HIV-1–Infected Men and Women enrolled in AIDS Clinical Trials Group Study A5077
Rami Kantor, Daniel Bettendorf, Ronald J. Bosch, Marita Mann, David Katzenstein, Susan Cu-Uvin, Richard D’Aquila, Lisa Frenkel, Susan Fiscus, Robert Coombs, for the ACTG A5077 Study Team
PLoS One. 2014; 9(4): e93537. Published online 2014 Apr 3. doi: 10.1371/journal.pone.0093537
PMCID:
PMC3974754
AbstractArticlePDF–507K
15.
HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation
Eleonora Olivetta, Valentina Tirelli, Chiara Chiozzini, Beatrice Scazzocchio, Ignazio Romano, Claudia Arenaccio, Massimo Sanchez
PLoS One. 2014; 9(4): e93699. Published online 2014 Apr 4. doi: 10.1371/journal.pone.0093699
PMCID:
PMC3976297
AbstractArticlePDF–4.5M
16.
Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users
Kristi Huik, Radko Avi, Merit Pauskar, Eveli Kallas, Ene-Ly Jõgeda, Tõnis Karki, Kristina Marsh, Don Des Jarlais, Anneli Uusküla, Irja Lutsar
Infect Genet Evol. Author manuscript; available in PMC 2014 Dec 1.
Published in final edited form as: Infect Genet Evol. 2013 Dec; 20: 78–82. Published online 2013 Aug 17. doi: 10.1016/j.meegid.2013.08.008
PMCID:
PMC4001117
AbstractArticlePDF–294K
17.
Frequency and Implications of HIV Superinfection
Andrew D. Redd, Thomas C. Quinn, Aaron A. R. Tobian
Lancet Infect Dis. Author manuscript; available in PMC 2014 Jul 1.
Published in final edited form as: Lancet Infect Dis. 2013 Jul; 13(7): 622–628. Published online 2013 May 31. doi: 10.1016/S1473-3099(13)70066-5
PMCID:
PMC3752600
AbstractArticlePDF–2.2M
18.
High-Level Cross-Resistance to Didanosine Observed in South African Children Failing an Abacavir- or Stavudine-Based 1st-Line Regimen
Kim Steegen, Leon Levin, Irene Ketseoglou, Michelle Bronze, Maria A. Papathanasopoulos, Sergio Carmona, Wendy Stevens
PLoS One. 2014; 9(5): e97067. Published online 2014 May 9. doi: 10.1371/journal.pone.0097067
PMCID:
PMC4016228
AbstractArticlePDF–1.5M
19.
CYP2B6 18492T→C Polymorphism Compromises Efavirenz Concentration in Coinfected HIV and Tuberculosis Patients Carrying CYP2B6 Haplotype *1/*1
Weerawat Manosuthi, Chonlaphat Sukasem, Supeda Thongyen, Samruay Nilkamhang, Sukanya Manosuthi, Somnuek Sungkanuparph
Antimicrob Agents Chemother. 2014 Apr; 58(4): 2268–2273. doi: 10.1128/AAC.02384-13
PMCID:
PMC4023787
AbstractArticlePDF–318K
20.
Impact of Y181C and/or H221Y mutation patterns of HIV-1 reverse transcriptase on phenotypic resistance to available non-nucleoside and nucleoside inhibitors in China
Wei Guo, Hanping Li, Daomin Zhuang, Liyan Jiao, Siyang Liu, Lin Li, Yongjian Liu, Tao Gui, Lei Jia, Jingyun Li
BMC Infect Dis. 2014; 14: 237. Published online 2014 May 5. doi: 10.1186/1471-2334-14-237
PMCID:
PMC4024112
AbstractArticlePDF–516K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center